Purpose

An intensive 13 weeks program that aims to improve glucose control in children with type 1 diabetes.

Conditions

Eligibility

Eligible Ages
Between 11 Years and 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  1. Age 11-18 years old 2. HbA1c > 8.5% 3. Duration of type 1 diabetes >1 year 4. Child uses Dexcom and has a phone that is compatible with the InPen app and Dexcom Clarity app.

Exclusion Criteria

Not able to attend telehealth visits

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
standard of care
standard of care will be given as per usual care
  • Other: telehealth visits
    intensive visits with doctor
Experimental
intensive monitoring
intensive monitoring every week will be given to participants
  • Other: telehealth visits
    intensive visits with doctor

Recruiting Locations

Medstar Pediatrics
Washington, District of Columbia 20007
Contact:
Barbara Runner
202-243-3560
diabetes@georgetown.edu

More Details

Status
Recruiting
Sponsor
Georgetown University

Study Contact

Detailed Description

Our new PeDi-BoCa Program aims to help children with type 1 diabetes achieve better diabetes control by interacting weekly with their doctor/nurse practitioner (NP) and also by using a "smart pen" that can facilitate the burden of daily calculations with the use of an app on the phone. Your child's doctor/NP will be able to remotely monitor your child's glucose every week (Dexcom) and make recommendations for changes, discuss solutions to possible obstacles and offer intensive diabetes education.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.